07.02.2013 Views

Bulletin 2011/50 - European Patent Office

Bulletin 2011/50 - European Patent Office

Bulletin 2011/50 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) II.1(1)<br />

(30) 27.06.2005 GB 0513069<br />

27.06.2005 GB 0513071<br />

28.07.2005 GB 0515556<br />

28.11.2005 GB 0524204<br />

21.12.2005 GB 0526041<br />

21.12.2005 GB 0526040<br />

(54) • IMMUNOGENE ZUSAMMENSETZUNG<br />

• IMMUNOGENIC COMPOSITION<br />

• COMPOSITION IMMUNOGÈNE<br />

(73) GlaxoSmithKline Biologicals s.a., rue de<br />

l'Institut 89, 1330 Rixensart Brussels, BE<br />

(72) BIEMANS, Ralph L., GlaxoSmithKline Biologicals<br />

s.a, B-1330 Rixensart, BE<br />

BOUTRIAU, Dominique, GlaxoSmithKline<br />

Bio. s.a., B-1330 Rixensart, BE<br />

CAPIAU, Carine, GlaxoSmithKline Biologicals<br />

s.a., B-1330 Rixensart, BE<br />

DENOEL, Philippe, GlaxoSmithKline Biologicals<br />

s.a., B-1330 Rixensart, BE<br />

DUVIVIER, Pierre, GlaxoSmithKline Biologicals<br />

s.a., B-1330 Rixensart, BE<br />

POOLMAN, Jan, GlaxoSmithKline Biologicals<br />

s.a., B-1330 Rixensart, BE<br />

(74) Johnston, Caroline Louise, GlaxoSmithKline<br />

Corporate Intellectual Property (CN925.1)<br />

980 Great West Road, Brentford Middlesex<br />

TW8 9GS, GB<br />

A61K 39/102 → (51) A61K 39/095<br />

A61K 39/116 → (51) A61K 39/095<br />

A61K 39/36 → (51) A61K 38/04<br />

(51) A61K 39/385 (11) 2 184 072 B1<br />

(25) Es (26) En<br />

(21) 08757902.5 (22) 26.06.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(43) 12.05.2010<br />

(86) CU 2008/000005 26.06.2008<br />

(87) WO 2009/003425 2009/02 08.01.2009<br />

(30) 29.06.2007 CU 20070154<br />

(54) • PRODUKTION EINER HOMOGENEN<br />

IMPFSTOFFZUBEREITUNG ZUR BEHAND-<br />

LUNG VON KREBS<br />

• PRODUCTION OF AN HOMOGENEOUS<br />

VACCINE PREPARATION FOR CANCER<br />

TREATMENT<br />

• PRODUCTION D'UNE PRÉPARATION<br />

VACCINALE HOMOGÈNE POUR LE TRAI-<br />

TEMENT DU CANCER<br />

(73) Centro de Inmunologia Molecular, Calle 216<br />

esq. A 15 Atabey Playa, Habana 11600, Cuba<br />

Ciudad De La Habana 11600, CU<br />

(72) RODRÍGUEZ MARTÍNEZ, Gryssell María,<br />

Ciudad De La Habana 11600, CU<br />

VIÑA RODRÍGUEZ, Lisel, Ciudad De La<br />

Habana 192<strong>50</strong>, CU<br />

CALVO GONZÁLEZ, Loany, Ciudad De La<br />

Habana 10600, CU<br />

CUEVAS FIALLO, Ariadna, Ciudad De La<br />

Habana 11<strong>50</strong>0, CU<br />

CHICO VELIZ, Ernesto, Ciudad De La Habana<br />

11600, CU<br />

CROMBET RAMOS, Tania, Ciudad De La<br />

Habana 10800, CU<br />

ALBISA NOVO, Airama, Ciudad De La Habana<br />

11<strong>50</strong>0, CU<br />

GONZÁLEZ MARINELLO, Gisela María, Ciudad<br />

De La Habana 11300, CU<br />

LAGE DÁVILA, Agustín Bienvenido, Ciudad<br />

De La Habana 11300, CU<br />

(74) Hatzmann, Martin, et al, Vereenigde Johan de<br />

Wittlaan 7, 2517 JR Den Haag, NL<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

A61K 39/395 → (51) C07K 16/28<br />

A61K 39/395 → (51) C12N 15/12<br />

A61K 45/00 → (51) C12N 9/16<br />

A61K 45/06 → (51) A61K 31/549<br />

A61K 47/06 → (51) A61L 26/00<br />

A61K 47/10 → (51) A61K 31/549<br />

(51) A61K 47/18 (11) 1 <strong>50</strong>3 798 B1<br />

A61K 38/48<br />

(25) En (26) En<br />

(21) 03720286.8 (22) 02.05.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 09.02.2005<br />

(86) DK 2003/000287 02.05.2003<br />

(87) WO 2003/092731 2003/46 13.11.2003<br />

(30) 03.05.2002 DK 200200677<br />

(54) • STABILISIERTE FESTE ZUSAMMENSET-<br />

ZUNGEN VON MODIFIZIERTER FAKTOR VII<br />

• STABILISED SOLID COMPOSITIONS OF<br />

MODIFIED FACTOR VII<br />

• COMPOSITIONS SOLIDES STABILISEES<br />

D'UN FACTEUR VII MODIFIE<br />

(73) NOVO NORDISK A/S, Novo Allé, 2880<br />

Bagsværd, DK<br />

(72) NEDERGAARD, Hanne, DK-2100 København,<br />

DK<br />

HANSEN, Lars, Lindgaard, DK-4621<br />

Gadstrup, DK<br />

KLAUSEN, Niels, Kristian, DK-2820 Gentofte,<br />

DK<br />

KORNFELT, Troels, DK-2830 Virum, DK<br />

FLINK, James, M., DK-2930 Klampenborg,<br />

DK<br />

(74) Nilsson, Karin Norvin, et al, Novo Nordisk A/<br />

S Corporate <strong>Patent</strong>s Novo Allé, 2880 Bagsværd,<br />

DK<br />

A61K 47/20 → (51) A61K 8/14<br />

A61K 47/26 → (51) A61K 8/14<br />

A61K 47/26 → (51) A61K 38/46<br />

A61K 47/34 → (51) A61K 9/22<br />

A61K 47/34 → (51) A61Q 19/00<br />

A61K 47/36 → (51) A61K 9/70<br />

A61K 47/38 → (51) A61K 9/22<br />

(51) A61K 47/48 (11) 1 531 851 B1<br />

A61K 38/00 A61K 38/40<br />

A61P 35/00 A61P 31/04<br />

(25) En (26) En<br />

(21) 03757380.5 (22) 06.06.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 25.05.2005<br />

(86) US 2003/017881 06.06.2003<br />

(87) WO 2003/103592 2003/51 18.12.2003<br />

(30) 06.06.2002 US 386928 P<br />

(54) • KOVALENTE KONJUGATE ZWISCHEN MIT<br />

ARTEMISININ VERWANDTEN ENDOPERO-<br />

XIDEN UND EISENTRAGENDEN PROTEI-<br />

NEN UND ANWENDUNGSVERFAHREN<br />

• COVALENT CONJUGATES BETWEEN<br />

ARTEMISININ-RELATED ENDOPEROXIDES<br />

AND IRON-CARRYING PROTEINS AND<br />

METHODS OF USE<br />

526<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>50</strong>/<strong>2011</strong>) 14.12.<strong>2011</strong><br />

• CONJUGUES COVALENTS ENTRE DES<br />

ENDOPEROXYDES LIES A L'ARTEMISI-<br />

NINE ET DES PROTEINES PORTEUSES DE<br />

FER ET PROCEDES D'UTILISATION<br />

ASSOCIES<br />

(73) University of Washington, <strong>Office</strong> of Technology<br />

Licensing, 4311 11th Avenue NE,<br />

Suite <strong>50</strong>0, Box 354990, Seattle, WA 98105-<br />

4608, US<br />

(72) LAI, Henry, C., Seattle, WA 98105, US<br />

SASAKI, Tomikazu, Bothell, WA 98012, US<br />

SINGH, Narendra, P., Lynnwood, WA 98037,<br />

US<br />

(74) Bizley, Richard Edward, et al, avidity IP<br />

Merlin House Falconry Court Baker's Lane,<br />

Epping, Essex CM16 5DQ, GB<br />

(51) A61K 47/48 (11) 1 809 332 B1<br />

A61K 51/04 A61P 35/00<br />

(25) En (26) En<br />

(21) 05802465.4 (22) 25.07.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 25.07.2007<br />

(86) US 2005/026248 25.07.2005<br />

(87) WO 2006/010165 2006/04 26.01.2006<br />

(30) 23.07.2004 US 897530<br />

(54) • ZUSAMMENSETZUNGEN ZUR MEHRSTU-<br />

FIGEN ANWENDUNG VON HOT-SPOT-<br />

BESTRAHLUNG AUF KREBSZELLEN<br />

• COMPOSITIONS FOR MULTI-STEP DELIV-<br />

ERY OF HOT-SPOTS RADIATION TO CAN-<br />

CER CELLS<br />

• COMPOSITIONS POUR L'ADMINISTRA-<br />

TION EN PLUSIEURS ETAPES DE<br />

RAYONNEMENT A HOT-SPOTS AUX CEL-<br />

LULES CANCEREUSES<br />

(73) Oncologic, Inc., 3065 Richmon Parkway,<br />

Suite 117, Richmond, CA 94806-5719, US<br />

(72) MAYERS, George, L., Gainesville, FL 32607,<br />

US<br />

LEE, David, Pleasant Hill, CA 94523, US<br />

CHIN, Hsiao-Ling, Moraga, CA 94556, US<br />

(74) Aston, Heidi Frances, et al, Mintz, Levin,<br />

Cohn, Ferris, Glovsky and Popeo IP, LLP<br />

Alder Castle 10 Noble Street, London EC2V<br />

7JX, GB<br />

A61K 47/48 → (51) A61K 9/46<br />

A61K 47/48 → (51) A61K 9/58<br />

A61K 48/00 → (51) C12N 15/88<br />

(51) A61K 49/00 (11) 1 641 492 B1<br />

C12Q 1/00 G01N 33/53<br />

G01N 33/567<br />

(25) En (26) En<br />

(21) 04756747.4 (22) 06.07.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />

TR<br />

(43) 05.04.2006<br />

(86) US 2004/021785 06.07.2004<br />

(87) WO 2005/007868 2005/04 27.01.2005<br />

(30) 08.07.2003 US 485703 P<br />

(54) • KONTROLLIERTE THROMBOZYTEN-AKTI-<br />

VIERUNG ZUR ÜBERWACHUNG DER<br />

BEHANDLUNG VON ADP-ANTAGONISTEN<br />

• CONTROLLED PLATELET ACTIVATION TO<br />

MONITOR THERAPY OF ADP ANTAGO-<br />

NISTS<br />

• ACTIVATION SELECTIVE DES PLAQUET-<br />

TES POUR SUIVIE DU TRAITEMENT AUX<br />

ANTAGONISTES DE L'ADP<br />

(73) Accumetrics, Inc., 3985 Sorrento Valley<br />

Blvd., San Diego, CA 92121, US<br />

(72) COLLER, Barry S., New York, NY 10128, US

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!